Meningiomas represent between 13 and

Size: px
Start display at page:

Download "Meningiomas represent between 13 and"

Transcription

1 RESEARCH EXPERIMENTAL (LABORATORY) Mitotic Count, Brain Invasion, and Location Are Independent Predictors of Recurrence-Free Survival in Primary Atypical and Malignant Meningiomas: A Study of 86 Patients Andrej Vranic, MD Department of Neurosurgery, University Medical Centre, Ljubljana, Slovenia Mara Popovic, MD, PhD Institute of Pathology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia Andrej Cör, MD, PhD College of Health Care Izola, University of Primorska, Izola, Slovenia Borut Prestor, MD, PhD Department of Neurosurgery, University Medical Centre, Ljubljana, Slovenia Joze Pizem, MD, PhD Institute of Pathology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia Reprint requests: Joze Pizem, MD, PhD Institute of Pathology, Medical Faculty, Ljubljana, 1000 Ljubljana, Slovenia. joze.pizem@mf.uni-lj.si Received, May 26, Accepted, April 12, BACKGROUND: Since precise diagnostic criteria for atypical and malignant meningiomas (AMMs) were provided for the first time in the 2000 World Health Organization (WHO) criteria, there is only sparse information about possible prognostic factors in the group of AMMs. OBJECTIVE: To evaluate the prognostic significance of various histological and clinical parameters in AMMs, with an emphasis on location, mitotic count, brain invasion, and Ki67 labeling index. METHODS: We analyzed 86 primary AMMs, 76 of which were atypical and 10 of which were malignant, diagnosed according to the 2000 WHO classification. Multivariate Cox survival analyses were performed. RESULTS: High mitotic count, brain invasion, and the parasagittal-falcine location of the tumor were significantly associated with decreased recurrence-free survival in multivariate analysis. Brain invasion was present in 25 of 37 cases in which brain tissue was identified in the tumor specimens. When brain invasion was not included in the analysis because of the limited number of cases in which it could be assessed, high mitotic count, Ki67 index.4%, the presence of macronucleoli, and parasagittal-falcine location were significant predictors of shorter recurrence-free survival. CONCLUSION: AMMs, as defined by 2000 WHO, are biologically heterogeneous. Recurrence-free survival can be further stratified by location and histological parameters, especially mitotic count, brain invasion, and Ki67 labeling index. Not only brain invasion, but also the presence or absence of brain tissue in surgical specimens should be reported, because the absence of brain invasion, when brain tissue is identified, provides very important positive prognostic information. KEY WORDS: Atypical meningioma, Brain invasion, Cleavability, Malignant meningioma, Mitotic count, Recurrence Neurosurgery 67: , 2010 DOI: /NEU.0b013e3181eb95b7 Copyright ª 2010 by the Congress of Neurological Surgeons Meningiomas represent between 13 and 26% of all intracranial tumors, with an annual incidence rate of approximately 6/ Although generally considered benign, meningiomas can cause significant morbidity and mortality. 2,3 Much effort has been ABBREVIATIONS: AMM, atypical and malignant meningioma; HPF, high-power field; OS, overall survival; RFS, recurrence-free survival; WHO, World Health Organization invested in identifying those meningiomas that are likely to pursue an aggressive clinical course. The 1993 World Health Organization (WHO) classification introduced meningioma grading into classic (WHO grade I), atypical (WHO grade II), and malignant (WHO grade III). 4 For the first time, histological features important for the diagnosis of atypical meningiomas were listed, but the extent of such features required for the diagnosis was not defined. Similarly, malignant meningiomas were vaguely defined as exhibiting histological features of frank 1124 VOLUME 67 NUMBER 4 OCTOBER

2 ATYPICAL AND MALIGNANT MENINGIOMAS malignancy, based on malignant cytology, a high mitotic index, and conspicuous necrosis. More precise criteria for meningioma grading were provided in the 2000 WHO classification. 5 Depending on the diagnostic criteria used in different studies, atypical meningiomas constitute between 5% and 17%, whereas malignant meningiomas constitute between 1% and 3% of all meningiomas. 1,2,6,7 The significance of brain invasion as a criterion of malignancy has been controversial. It has been traditionally considered to be indicative of malignancy, 2,3,8 but it was shown recently that brain-invasive meningiomas without anaplasia (ie, otherwise benign or atypical meningiomas) pursue a less aggressive course than histologically malignant meningiomas. 3 The 2000 WHO classification acknowledges that brain invasion increases the risk of recurrence but does not specifically recommend that otherwise benign meningiomas that invade the brain should be classified as atypical (or malignant). 1,5 According to the latest 2007 WHO classification, otherwise benign meningiomas with brain invasion should be considered WHO grade II. 6 The usefulness of brain invasion as a marker of meningioma aggressiveness is limited by the fact that brain tissue is identified only in a minority of surgical specimens and it is often not reported by pathologists. 2,3,7,9 We identified only 8 studies published since 1990 with a survival analysis that included more than 50 cases of either atypical or malignant meningiomas. 2,3,7,9-13 It is difficult to compare and interpret the results of these studies, because different diagnostic (grading) criteria were applied (2000 WHO, 1993 WHO, or even older criteria), different proportions of atypical and malignant, primary, and recurrent cases were included, and sometimes brain invasion was used as a criterion for malignancy. 2,3,7,9-13 To the best of our knowledge, only 3 studies have included more than 50 cases of either atypical or malignant meningiomas diagnosed according to the 2000 WHO grading criteria. 2,3,12 In only one of them was the prognostic significance of brain invasion and mitotic count in primary meningiomas studied. 2 In the present study, we analyzed 86 consecutive primary atypical (WHO grade II) and malignant (WHO grade III) meningiomas, diagnosed according to 2000 WHO and treated at a single institution. Our aim was to determine prognostic factors in atypical and malignant meningiomas, with an emphasis on location, brain invasion, mitotic count, and Ki67 labeling index. METHODS Patients Eighty-six consecutive patients with WHO grade II (atypical) and WHO grade III (malignant) meningiomas diagnosed between 1990 and 2005 were included in the study. In the same period, 790 primary benign meningiomas were diagnosed. All patients were surgically treated at the Department of Neurosurgery, University Medical Centre, Ljubljana, Slovenia, and histologically diagnosed at the Institute of Pathology, Medical Faculty, Ljubljana, Slovenia. The selection of patients was based on the original pathological reports. All original histological slides were reviewed when the original diagnosis was either atypical or malignant meningioma, or any atypical feature was mentioned in the report in a meningioma considered benign. Because reporting of atypical and malignant meningiomas was inconsistent before 1997, we reevaluated all meningiomas (including benign), diagnosed between 1990 and Only primary meningiomas that met the 2000 WHO diagnostic criteria 5 for atypical or malignant meningioma at reevaluation (see below) were included in the study. Meningiomas diagnosed as either atypical or malignant at recurrence were excluded. The selection of patients was not based on or influenced by the presence of brain invasion. Clinical data, including location, size, signs, and symptoms and their duration, extent of surgical resection according to the Simpson grade, 14 presence of brain edema, cleavability, and information on radiation therapy after surgical resection of a primary tumor were retrieved from the patients medical records. Brain edema was graded as absent, mild, or severe. Data on cleavability were obtained from original operative reports with special emphasis on the tumor/brain interface. According to Sindou et al, 15 meningiomas were classified as noncleavable when pial invasion was observed by the surgeon and cleavable when dissection in the extrapial plane could be performed. Follow-up data were collected for all patients, including recurrencefree survival (RFS, time from surgical resection to local recurrence) and overall survival (OS, time from surgical resection to death). The dates of patients death were collected from the Cancer Registry of Slovenia. No attempts were made to determine the cause of death. Pathological Review All original histological slides of each case were reviewed without knowledge of clinical outcome and other clinical data. The number of tissue blocks per meningioma included in the study ranged from 2 to 17 (mean, 6). The following histological parameters were assessed: mitotic count, presence of atypical mitoses, necrosis, significant pleomorphism, macronucleoli, sheeting (patternless growth), foci of small cells, hypercellularity, presence of brain tissue, presence of brain invasion, and at least focal, clearly malignant appearance (carcinoma-, sarcoma-, or melanoma-like). 5 The mitotic count was defined as the number of mitoses per 10 high-power fields (HPFs). The mitoses were counted in 10 consecutive HPFs in the area with the most prominent mitotic activity. Necrosis was assessed as present or absent regardless of the extent or type (spontaneous or infarct-like). Brain invasion was defined as irregular projections of tumor into adjacent brain tissue without an intervening layer of leptomeninges. Meningiomas having $4 mitoses per 10 HPFs or displaying at least 3 of 5 features, including sheeting, macronucleoli, small-cell formation, hypercellularity, and necrosis, were classified as atypical. Meningiomas having $20 mitoses per 10 HPFs or displaying at least focal carcinoma-, sarcoma-, or melanoma-like appearance were classified as malignant. In addition, clear cell and chordoid meningiomas were considered WHO grade II (atypical) and rhabdoid meningiomas were considered WHO grade III (malignant), regardless of the criteria listed above. 5 In this study, we used the designations atypical synonymous with WHO grade II and malignant synonymous with WHO grade III. In most cases, Ki67 proliferative indices were determined at the time of original diagnoses. In all other cases, we performed Ki67 immunostaining at the time of slide review. We also performed progesterone receptors immunostaining in all cases. Immunohistochemistry was performed according to the routine protocols used in everyday practice at the Institute of Pathology, Ljubljana. We used monoclonal mouse anti-human Ki67 antibody, clone MIB-1 (DAKO, Glostrup, Denmark), at a dilution of 1:20, and monoclonal mouse anti-human progesterone receptor antibody, NEUROSURGERY VOLUME 67 NUMBER 4 OCTOBER

3 VRANIC ET AL clone 1A6 (Novocastra, Newcastle upon Tyne, UK), at a dilution of 1:20. The Ki67 labeling index was determined as a percentage of positive tumor cell nuclei in the area of most prominent positivity by systematically counting at least 1000 tumor cell nuclei. Statistical Analysis The statistical analysis was performed with SPSS for Windows (SPSS Inc., Chicago, Illinois). The differences between groups in relation to other clinicopathological parameters were analyzed by Kruskal-Wallis and x 2 tests. Survival analysis was performed by the Cox model and survival curves were estimated using the Kaplan-Meier method. The final multivariate models were achieved using a stepwise backward elimination of non-significant variables. RESULTS We analyzed 86 consecutive primary atypical and malignant (WHO grades II and III) meningiomas (AMMs) diagnosed between 1990 and Among 86 AMM cases, 76 (88%) were atypical and 10 (12%) were malignant. A diagnosis of WHO grade II meningiomas was made solely on the basis of mitotic count ($4 mitoses/10 HPF) in 13 (17%) cases and solely on the basis of at least 3 criteria, including hypercellularity, sheeting, macronucleoli, necrosis, and small-cell formation in 22 (29%) cases (including 2 clear-cell meningiomas). Both criteria were met in 38 (50%) cases (including one clear-cell meningioma). Three cases (4%) were considered WHO grade II attributed to the histological type (2 clear-cell meningiomas, one chordoid) without other criteria for atypical meningiomas. A diagnosis of WHO grade III meningiomas was based solely on mitotic count in one case ($20 mitoses/10 HPFs), obvious malignant histological features in 7 cases (including one rhabdoid), and on both in two cases. Clinical and pathological characteristics of 86 AMMs are shown in Tables 1 and 2, respectively. There was no difference in the various clinical parameters presented in Table 1, including sex, age, size, location, signs, and symptoms and their duration, cleavability, and the extent of resection between atypical and malignant groups. Brain edema was strongly associated with malignant meningiomas (P =.002); severe edema was present in all 5 malignant meningiomas with available data. There was no correlation between cleavability and brain edema. Male patients were younger (mean, 52.8 years) than female (mean, 57.2 years), but the difference was not statistically significant (P =.189). There were no associations between sex and WHO grade, location, mitotic count, or Ki67 index. Simpson grade I resection was achieved in 6 of 24 (25%) parasagittal-falcine meningiomas and in 30 of 53 (57%) meningiomas of other locations (P =.014). The information on radiation therapy was available for 67 patients with atypical and 9 patients with malignant meningiomas. Only 3 patients with atypical (one with a residual tumor in the bone, one with a residual tumor in the sagittal sinus, and one with an original diagnosis of malignancy) and 3 with malignant meningiomas (3 patients refused radiation therapy; 3 malignant meningiomas were originally diagnosed as atypical) received radiation therapy after surgical resection of the primary tumor. TABLE 1. Clinical Characteristics of 86 Cases of Atypical and Malignant Meningiomas Parameter n (%) a Sex 86 Male 42 (48.8) Female 44 (51.2) Age, y 86 Range, Mean, 55.0 Median, 57.2 Size, cm 78 Range, Mean, 4.9 Median, 5.0 Location 86 Parasagittal-falcine 26 (30.2) Convexity 35 (40.7) Base 24 (27.9) Intraspinal 1 (1.1) Duration of signs/symptoms, mo 80 Range, 0-36 Mean, 7.5 Median, 4.0 Signs/symptoms 81 Paresis 28 (36.6) Headache 21 (25.9) Seizures 20 (24.7) Others 9 (11.1) Simpson grade 77 I 36 (46.8) II 33 (42.9) III 5 (6.5) IV 3 (3.9) Edema 58 Absent 10 (17.2) Mild 31 (53.4) Severe 17 (29.3) Cleavability 42 Cleavable 18 (42.9) Noncleavable 24 (57.1) Radiation therapy 76 Yes 6 (7.9) No 70 (92.1) a The information on size, signs/symptoms, Simpson grade, edema, cleavability, and radiation therapy was not available for all patients. Brain tissue was identified in 37 (43%) tumor specimens. Of these 37 cases, brain invasion was present in 25 (67.6%) cases and absent in 12 (32.4%) cases. Brain tissue in surgical specimens was found more frequently in larger tumors (P =.012) and was strongly associated with the presence of brain edema (P =.003). Brain tissue was not identified in any of 10 cases without brain edema, whereas it was found in 16 of 31 (51.6%) cases with mild brain edema and in 11 of 17 (64.7%) cases with severe brain edema. The finding of brain tissue tended to be related to the higher number of tissue blocks examined (P =.103), tended to be more frequent in malignant meningiomas (P =.092), and was not 1126 VOLUME 67 NUMBER 4 OCTOBER

4 ATYPICAL AND MALIGNANT MENINGIOMAS TABLE 2. Pathological Characteristics of 86 Cases of Atypical and Malignant Meningiomas Parameter All (n = 86), n (%) Atypical (n = 76), n (%) Malignant (n = 10) P Value Histological type Meningothelial 52 (60.5) 49 (64.5) 3 Transitional 17 (19.8) 17 (22.4) 0 Fibroblastic 4 (4.6) 4 (5.3) 0 Clear cell 5 (5.8) 5 (6.6) 0 Chordoid 2 (2.3) 1 (1.3) 1 Secretory 1 (1.2) 0 1 Rhabdoid 1 (1.2) 0 1 Not apparent 4 (4.6) 0 4 Brain tissue (present) 37 (43.0) 30 (39.5) Brain invasion (present) 25 (67.6) 19 (63.3) 6 (86).389 Mitotic count Range, 0-40 Range, 0-15 Range, 6-40,.001 Mean, 6.3 Mean, 4.9 Mean, 16.6 Median, 5.0 Median, 5.0 Median, 11.5 Atypical mitoses (present) 15 (17.4) 8 (10.5) 7,.001 Necrosis (present) 49 (57.0) 41 (53.9) Macronucleoli (present) 57 (66.3) 49 (64.5) Sheeting (present) 62 (72.1) 52 (68.4) Increased cellularity (present) 69 (80.2) 61 (60.2) Small cells (present) 54 (62.8) 52 (68.4) Pleomorphism (present) 46 (53.5) 39 (51.3) Ki67 (%) Range, Range, Range, ,.001 Mean, 9.4 Mean, 8.1 Mean, 19.5 Median, 6.8 Median, 6.0 Median, 21.3 Ki67 (.4 %) 58 (67.4) 48 (63.2) Progesterone receptors (positive) 10 (11.6) 8 (10.5) related to the location of the tumor or cleavability. Brain invasion was associated with a higher mitotic count (mean, 9.0 for invasive and mean, 4.8 for noninvasive; P =.019) and tended to be more frequent in males (14 of 17 males and 11 of 20 females, P =.077). It was not associated with age, size of the tumor, location, Simpson grade, brain edema, cleavability, WHO grade, the presence of atypical mitoses, or Ki67 index. Progesterone receptors were positive in 10 cases (11.6%). Of the positive cases, up to 5% of tumor cell nuclei were positive in 3 cases, 6% to 50% of nuclei in 6 cases, and more than 50% in one case. Patients were followed up until death or for a median of 96 months (range, mo). At the time of follow-up, the tumor had recurred in 31 patients (36%), from 4 to 76 months (median, 31) after the diagnosis, whereas 37 patients (43%) died, from 0 to 216 months (median, 45) after the diagnosis. The 5- and 10-year RFS for the entire group of 86 AMMs was 60% (95% CI, 48-71) and 55% (95% CI, 43-68), respectively. The 5- and 10-year OS was 76% (95% CI, 67-86) and 56% (95% CI, 44-68), respectively. The univariate Cox analyses of the RFS and OS are shown in Table 3. There were significant differences in RFS among noninvasive, invasive atypical, and invasive malignant meningiomas (Figure 1). None of the 7 cases of atypical meningiomas, including 2 brain-invasive, with a mitotic count of 0, recurred. A Ki67 index.4% was associated with decreased RFS, not only in the entire group of 86 AMMs, but also in the subgroup of 76 atypical meningiomas (HR, 2.7; P =.036). Kaplan-Meier survival curves of RFS according to the Ki67 index and location are shown in Figures 2 and 3, respectively, and of OS for brain-invasive and non brain-invasive meningiomas in Figure 4. Because brain invasion was assessable in only 37 cases, separate multivariate analyses of RFS and OS were performed with and without brain invasion (Table 4). High mitotic count, the presence of macronucleoli, high Ki67 index, and parasagittalfalcine location were independent negative predictors of RFS when brain invasion was not included, whereas high mitotic count, brain invasion, and parasagittal-falcine location were independent negative predictors of RFS when brain invasion was included. Male sex and parasagittal-falcine location were the only parameters associated with decreased OS in both analyses, with and without brain invasion. DISCUSSION In our series of 86 consecutive primary AMMs treated at a single institution and diagnosed according to 2000 WHO criteria, we showed that mitotic count (as a continuous variable), brain invasion (when assessable), and location were the most powerful predictors of RFS. In addition to mitotic count and parasagittal-falcine location, Ki67 index.4% and the presence of macronucleoli were significantly associated with decreased RFS in multivariate analysis, when brain invasion was not included because of the limited number of cases in which it could be assessed. NEUROSURGERY VOLUME 67 NUMBER 4 OCTOBER

5 VRANIC ET AL TABLE 3. Univairate Cox Survival Analysis a Recurrence-Free Survival Overall Survival Variable n HR 95% CI P Value HR 95% CI P Value Sex (male vs female) Age ($55 vs,55) Size, cm Location (parasagittal-falcine vs others) Simpson grade 77 II vs I III and IV vs I Edema 58 Mild vs absent Severe vs absent Cleavability (noncleavable vs cleavable) Radiation therapy (yes vs no) WHO grade (III vs II) Necrosis (present vs absent) Pleomorphism (present vs absent) Sheeting (present vs absent) Macronucleoli (present vs absent) Small cells (present vs absent) Hypercellularity (present vs absent) Mitotic count (continuous) Atypical mitoses (present vs absent) Brain tissue (absent vs present) Brain invasion when assessable (present vs absent) Ki67 (%) Ki67 (.4% vs #4%) Progesterone receptors (positive vs negative) a HR, hazard ratio; CI, confidential interval; WHO, World Health Organization. Bold P values are considered statistically significant.. Male sex and parasagittal-falcine location were 2 independent predictors of shorter OS. We consider the results of OS less relevant, because it is difficult to determine disease-related death in meningioma patients. 2,3,6 Our results show that the group of AMMs as defined by 2000 WHO is biologically heterogeneous and RFS can be further stratified by histological parameters, especially mitotic count, brain invasion, and Ki67 labeling index. AMMs as a group represent from 6% to 23% of meningiomas. 2,5,12,16-19 The differences in reported frequencies reflect different grading criteria used, the highest frequencies being reported with more current definitions, 2,6,17 and possibly poor adherence to the WHO criteria in everyday practice, because the grading of meningiomas is relatively tedious work, requiring examination of many slides and consideration of several histological features. 5 It is clear that many cases of AMMs, diagnosed before the 2000 WHO classification, were either underdiagnosed or overdiagnosed compared with 2000 WHO criteria. 12,17 The reported ratio of atypical relative to malignant meningiomas has been from approximately 1.5:1 to 6:1. 7,10-12,18,19 The large proportion of malignant meningiomas in some studies of AMMs may well be attributed to overdiagnosing meningiomas as malignant. 12,20 In our study, AMMs represented approximately 10% of all primary meningiomas; the ratio of atypical vs malignant was 7.6:1. Although benign meningiomas are more common in women (female to male ratio of approximately 2:1), AMMs are relatively more frequent in men (female to male ratio, :1). 3,9-12,18,21 In our series, the female to male ratio was 1.1:1. Male sex tended to be associated with decreased RFS and OS in univariate analysis and was an independent predictor of OS in multivariate analysis, together with location of the tumor. A similar trend of a worse prognosis of AMMs in male patients has been reported in other studies, 9,21 but no association between sex and prognosis was found in most studies. 3,10-12 In our series, the RFS of malignant cases was shorter than that of atypical, but the difference was only of marginal significance. In multivariate analysis, WHO grade had no prognostic significance, which is probably attributable to a strong correlation between the WHO grade and both mitotic count and Ki67 index. Although limited by the small number of malignant cases, our results suggest that malignant cases represent only the end of a continuous atypical spectrum in terms of mitotic activity and the extent of other histological parameters. Whereas most studies showed 1128 VOLUME 67 NUMBER 4 OCTOBER

6 ATYPICAL AND MALIGNANT MENINGIOMAS FIGURE 1. Kaplan-Meier curves of recurrence-free survival for noninvasive, brain-invasive atypical, brain-invasive malignant meningiomas, and meningiomas in which brain invasion could not be assessed (HR = 4.4, P =.019, for invasive malignant vs invasive atypical; HR = 23.1, P =.005, for invasive malignant vs noninvasive; HR = 5.2, P =.123, for invasive atypical vs noninvasive). The survival curve for meningiomas in which brain invasion could not be assessed is similar to that of invasive atypical meningiomas and is only slightly above the combined curve (not shown) for all invasive meningiomas (atypical and malignant). significantly shorter survival of malignant meningiomas, 3,11-13 this finding could be attributed, to some extent, to a selection bias and grading criteria. 3,11,12 Nevertheless, we believe that malignant meningiomas, although rare, can be reproducibly diagnosed and their recognition is clinically relevant. 1 FIGURE 3. Kaplan-Meier curves of recurrence-free survival according to location (HR = 2.7, P =.023, for parasagittal-falcine vs convexity location, the differences between base meningiomas and the other 2 groups were not statistically significant). The prognostic significance of mitotic count as a continuous variable in AMMs has not been analyzed in previous studies. 3,7,9-13 Perry et al 3 reported mitotic counts of either $4 or$20 (the cutoffs for atypical and malignant) to be associated with decreased OS, but in a heterogeneous group of meningiomas, which consisted of malignant and otherwise atypical or benign meningiomas with brain invasion. Pasquier et al 10 reported high mitotic count to be a negative prognostic marker in multivariate analyses of RFS and OS in a series of 119 AMMs, but the cutoff value was not stated. On the other hand, in a recent study of AMMs by Aghi FIGURE 2. Kaplan-Meier curves of recurrence-free survival according to the Ki67 labeling index (HR = 2.7, P =.027, for.4% vs 0%-4%). FIGURE 4. Kaplan-Meier curves of overall survival for brain invasive and nonbrain invasive meningiomas (HR = 4.4, P =.049). NEUROSURGERY VOLUME 67 NUMBER 4 OCTOBER

7 VRANIC ET AL TABLE 4. Multivariate Cox Survival Analyses a Variables HR 95% CI P Value Recurrence free survival, without brain invasion (n = 86) Mitotic count (continuous) Ki67 (.4% vs #4%) Macronucleoli (present vs absent) Location (parasagittal-falcine vs others) Recurrence-free survival, with brain invasion (n = 37) Mitotic count (continuous) Brain invasion (present vs absent) Location (parasagittal-falcine vs others) Overall survival (n = 86) Sex (male vs female) Location (parasagittal-falcine vs others) a HR, hazard ratio; CI, confidential interval. et al, 9 mitotic count was not a statistically significant predictor of RFS (although there was a trend toward worse survival) but, again, the cutoff value was not stated. Nevertheless, these studies and the cornerstone study of meningioma grading by Perry et al 2 indicate the importance of mitotic count for risk stratification of AMMs. Perry et al 2 showed that AMMs are not a homogeneous group and the RFS of those AMMs diagnosed solely on the basis of 3 of 5 criteria, with mitotic count,4, was better compared with AMMs with a mitotic count $4. As can be anticipated from the diagnostic criteria, there was a very wide distribution of mitotic count in our series of AMMs and there was a considerable overlap between atypical and malignant cases. We showed that mitotic count as a continuous variable can be a valuable tool to further stratify the risk of recurrence of AMMs. Indeed, the mitotic count has been incorporated in treatment algorithms of AMM. 1 The importance of brain invasion as a determinant of poor survival and for meningioma grading has been controversial. 1,3,5,6 The most important shortcoming is the fact that brain invasion is assessable only in a proportion of cases, when brain tissue is present in the surgical tumor specimen. 3 We identified brain tissue in 37 of 86 (43%) AMMs. Perry et al 2 identified brain tissue in 89 of 581 (15%) consecutive primary meningiomas (benign, atypical, and malignant). On the other hand, Yang et al reported brain tissue in 56 of 64 (88%) AMM tumor specimens, but they stated that adjacent brain parenchyma was intentionally removed to assess the brain invasion, when a clear arachnoid plain disappeared. 12 The presence of brain tissue seems therefore to be highly related to a surgeon s approach. Other factors potentially associated with the likelihood of brain tissue being identified could be: the size and location of the tumor, grade of the tumor, invasive growth, cleavability, and the number of tissue blocks examined from a given tumor. In our series, brain tissue was more often present in larger tumors and in cases with brain edema. It was not related to the location or cleavability 15 but tended to be more often present in malignant meningiomas and in cases with a higher number of tissue blocks examined. Since there was no difference in the RFS in relation to the presence of brain tissue in surgical specimens, it seems that the removal of brain tissue during surgery is not directly related to invasion itself (ie, the likelihood of a meningioma being invasive when no brain tissue is identified seems not to be different than for a meningioma with brain tissue identified). In the literature, little attention has been paid to the assessability of brain invasion and its relation to factors associated with it. 7,9-11 Since the importance of brain invasion in predicting meningioma aggressiveness has been emphasized only recently, 2,3,5,6 it is very likely that brain invasion and brain invasion assessability have been underreported. To increase the assessability of brain invasion, an important prognostic determinant, we recommend thorough sampling and examination of the surgical meningioma specimens, especially the surface of the tumor. 2 In our series, 25 AMMs were brain invasive of 37 (68%) AMMs in which brain invasion could be assessed. Similarly to our results, Yang et al 12 reported brain invasion in 41 of 56 (73%) AMM cases in which brain invasion could be assessed. The frequencies of brain invasion in different meningioma grades are difficult to estimate because the assessability of brain invasion among grades is usually not specified, but it is probably approximately 10% in otherwise benign, 50% to 70% in otherwise atypical, and 80% to 90% in malignant meningiomas. 2,12 Because brain invasion can usually be assessed in a minority of meningiomas, most brain-invasive meningiomas remain unrecognized. According to our results, brain invasion in AMM cannot be predicted by brain edema or cleavability. 15,22,23 In accordance with the study by Perry et al, 3 the RFS of brain-invasive atypical meningiomas was significantly better than for invasive malignant meningiomas. On the other hand, the RFS of atypical meningiomas without brain invasion (but brain tissue identified in surgical specimens) tended to be better than that of brain-invasive atypical meningiomas. Similar results were reported by Perry et al 2 in a subset of 76 meningiomas of all grades in which brain invasion could be assessed. Although often studied and even used in everyday diagnostics of meningiomas, the prognostic significance of the Ki67 index still remains poorly defined. 1,6,19 Ki67 indices significantly increase from benign through atypical and malignant meningiomas, but there is a considerable overlap between different grades. 6,12,19,24 The principal limitation of the Ki67 index seems to be the lack of standardization of the technique and difficulties in defining cutoff values. 1,6,12,24 In most larger series of AMMs, the Ki67 index has not been reported. 2,7,10,11 In line with our results, Aghi et al 9 failed to show any prognostic significance of the Ki67 index as a continuous variable in a series of atypical meningiomas but, in their study, no attempt was made to categorize Ki67 indices. Yang et al 12 showed a Ki67 index of.5% to be of borderline significance for RFS in malignant but not atypical meningiomas. In a series of primary meningiomas (benign, atypical, and 1130 VOLUME 67 NUMBER 4 OCTOBER

8 ATYPICAL AND MALIGNANT MENINGIOMAS malignant), Perry et al 25 reported a Ki67 index $4.2% associated with decreased RFS in univariate but not in multivariate analysis with mitotic count, in which the latter was the only prognostic factor. The authors concluded that the Ki67 index appears to be of greatest value in evaluating meningiomas with borderline atypia. Because there is only limited information on the prognostic significance of the Ki67 index in AMM and possible cutoff values, we decided on a cutoff value of.4%, similar to that used by Perry et al. 1,3,25 All malignant and 63% atypical meningiomas had a Ki67 index.4%. In the entire group of AMMs, a Ki67 index.4% was an independent predictor of poor RFS in multivariate analysis, but lost its prognostic significance when brain invasion was included in the analysis. Our study indicates an important role of the Ki67 labeling index in risk stratification of AMM. 1 The prognostic significance of other histological parameters, such as necrosis, pleomorphism, macronucleoli, sheeting, increased cellularity, and small cells, is difficult to interpret because most of them are also among inclusion criteria for AMM. Nevertheless, our results show that some of them (macronucleoli, pleomorphism) could be prognostically more important than others. In accordance with a recent study, 9 the presence of macronucleoli was associated with decreased RFS in multivariate analysis. Similarly to benign meningiomas, the extent of surgical resection of AMM is prognostically important. 2,3,11,12,26 It is difficult to compare the results of different studies because the extent of resection is reported according to Simpson grade in some 11,12 and as gross total vs subtotal in others. 2,3,10 Moreover, the extent of resection considerably varies among studies. 2,3,10-12 In our series, Simpson grade I resection was achieved in 47% of patients and gross total resection (Simpson grades I and II) in 90% of patients, being more radical compared with other studies. 3,10-12 The RFS of patients with Simpson grade I resection tended to be better compared with Simpson grades II to IV, but it was not statistically significant. The survival of patients with convexity meningiomas, including AMMs, seems to be better compared with meningiomas of other locations, partially but not entirely attributed to the resectability of the tumor. 1,11,12 As noted in previous reports, 26 we found that parasagittal-falcine AMMs present with the highest recurrence rates, probably because residual tumor remains along the superior sagittal sinus. 1 Prognostic significance of cleavability has not been studied in AMMs. 15,23 In the univariate analyses, the RFS and OS of patients with cleavable meningiomas tended to be better compared with noncleavable meningiomas. Although cleavability is not correlated with brain invasion, it may have some prognostic value. AMMs, as defined by the 2000 WHO, are biologically heterogeneous and recurrence-free survival can be further stratified by histological parameters, especially mitotic count, brain invasion, and Ki67 labeling index. Brain invasion and mitotic count as a continuous variable are the two 2 most important parameters associated with the recurrence-free survival of AMM. The Ki67 labeling index may provide useful prognostic information, especially when brain tissue is not identified in the surgical specimen and brain invasion cannot be assessed. The mitotic count and brain invasion should be included in pathological reports of all meningiomas. Not only brain invasion, but also the presence or absence of brain tissue in surgical specimens should be reported, because the absence of brain invasion when brain tissue is identified provides very important positive prognostic information. Because of the importance of brain invasion, the surgical specimens of meningiomas should be thoroughly sampled and histologically examined. Disclosure The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article. REFERENCES 1. Modha A, Gutin PH. Diagnosis and treatment of atypical and malignant meningiomas: a review. Neurosurgery. 2005;57(3): PerryA,StaffordSL,ScheithauerBW,SumanVJ,LohseCM.Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol. 1997;21(12): Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC. Malignancy in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer. 1999;85(9): Kleihues P, Burger PC. Scheithauer BW. Histological Typing of Tumours of the Central Nervous System. Berlin, Germany: Springer-Verlag; Kleihues P, Cavenee WK, ed. World Health Organisation Classification of Tumours: Pathology and Genetics of Tumours of the Central Nervous System. Lyon, France: IARC Press; Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, ed. World Health Organisation Classification of Tumours: WHO Classification of Tumours of the Central Nervous System. Lyon, France: IARC Press; Kallio M, Sankila R, Hakulinen T, Jääskeläinen J. Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery. 1992;31(1): Stafford SL, Perry A, Suman VJ, et al. Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through Mayo Clin Proc. 1998;73(10): Aghi MK, Carter BS, Cosgrove GR, et al. Long-term recurrence of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery. 2009;64(1): Pasquier D, Bijmolt S, Veninga T, et al. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys. 2008;71(5): Palma L, Celli P, Franco C, Cervoni L, Cantore G. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J Neurosurg. 1997;86(5): Yang SY, Park CK, Park SH, Kim DG, Chung YS, Jung HW. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry. 2008;79(5): Maier H, Ofner D, Hittmair A, Kitz K, Budka H. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg. 1992;77(4): Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20(1): Sindou M, Alaywan M. Most intracranial meningiomas are not cleavable tumours: anatomic-surgical evidence and angiographic predictability. Neurosurgery. 1998; 42(3): Goyal LK, Suh JH, Mohan DS, Prayson RA, Lee J, Barnett GH. Local control and overall survival in atypical meningioma: a retrospective study. Int J Radiat Oncol Biol Phys. 2000;46(1): Smith SJ, Boddu S, Macarthur DC. Atypical meningiomas: WHO moved to the goalposts? Br J Neurosurg. 2007;21(6): Mahmood A, Caccamo DV, Tomecek FJ, Malik GM. Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery. 1993;33(6): NEUROSURGERY VOLUME 67 NUMBER 4 OCTOBER

9 VRANIC ET AL 19. Roser F, Samii M, Ostertag H, Bellinzona M. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir (Wien). 2004;146(1): Younis GA, Sawaya R, DeMonte F, Hess KR, Albrecht S, Bruner JM. Aggressive meningeal tumors: review of a series. Neurosurgery. 1995;82(1): McCarthy BJ, Davis FG, Freels S, et al. Factors associated with survival in patients with meningioma. J Neurosurg. 1998;88(5): Mantle RE, Lach B, Delgado MR, Baeesa S, Belanger G. Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning. J Neurosurg. 1999;91(3): Alvernia JE, Sindou MP. Preoperative neuroimaging findings as a predictor of the surgical plane of cleavage: prospective study of 100 consecutive cases of intracranial meningioma. J Neurosurg. 2004;100(3): Ho DM, Hsu CY, Ting LT, Chiang H. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer. 2002;94(5): Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer. 1998;82(11): Dziuk TW, Woo S, Butler EB, et al. Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy. J Neuro-Oncol. 1998;37(2): 1132 VOLUME 67 NUMBER 4 OCTOBER

Prognostic Factors of Atypical Meningioma : Overall Survival Rate and Progression Free Survival Rate

Prognostic Factors of Atypical Meningioma : Overall Survival Rate and Progression Free Survival Rate Clinical Article J Korean Neurosurg Soc 60 (6) : 661-666, 2017 https://doi.org/10.3340/jkns.2017.0303.008 pissn 2005-3711 eissn 1598-7876 Prognostic Factors of Atypical Meningioma : Overall Survival Rate

More information

Stereotactic Radiosurgery of World Health Organization Grade II and III Intracranial Meningiomas

Stereotactic Radiosurgery of World Health Organization Grade II and III Intracranial Meningiomas Stereotactic Radiosurgery of World Health Organization Grade II and III Intracranial Meningiomas Treatment Results on the Basis of a 22-Year Experience Bruce E. Pollock, MD 1,2 ; Scott L. Stafford, MD

More information

Meningiomas are the most common type of primary. Atypical meningiomas: is postoperative radiotherapy indicated?

Meningiomas are the most common type of primary. Atypical meningiomas: is postoperative radiotherapy indicated? Neurosurg Focus 35 (6):E15, 2013 AANS, 2013 Atypical meningiomas: is postoperative radiotherapy indicated? Kangmin D. Lee, M.D., 1,5 John J. DePowell, M.D., 1 Ellen L. Air, M.D., Ph.D., 1,3,4 Alok K. Dwivedi,

More information

Rapid recurrence of a malignant meningioma: case report

Rapid recurrence of a malignant meningioma: case report Romanian Neurosurgery Volume XXXI Number 2 2017 April-June Article Rapid recurrence of a malignant meningioma: case report Oguz Baran, Sima Sayyahmeli, Taner Tanriverdi, Pamir Erdincler TURKEY DOI: 10.1515/romneu-2017-0027

More information

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM MENINGIOMA CNS Site Group Meningioma Author: Dr. Norm Laperriere Date: February 20, 2018 1. INTRODUCTION 3 2. PREVENTION

More information

Title. CitationPLOS One, 9(5): e Issue Date Doc URL. Rights(URL) Type.

Title. CitationPLOS One, 9(5): e Issue Date Doc URL. Rights(URL)   Type. Title Prognostic Factors for Survival in Patients with Hig Application of Radiotherapy Yamaguchi, Shigeru; Terasaka, Shunsuke; Kobayashi, H Author(s) Hiroshi; Kanno, Hiromi; Onimaru, Rikiya; Ito, Yoichi

More information

Research Article Prognostic Implication of Preoperative Behavior Changes in Patients with Primary High-Grade Meningiomas

Research Article Prognostic Implication of Preoperative Behavior Changes in Patients with Primary High-Grade Meningiomas e Scientific World Journal Volume 2014, Article ID 398295, 5 pages http://dx.doi.org/10.1155/2014/398295 Research Article Prognostic Implication of Preoperative Behavior Changes in Patients with Primary

More information

Original Article The potential risk factors for atypical and anaplastic meningiomas: clinical series of 1,239 cases

Original Article The potential risk factors for atypical and anaplastic meningiomas: clinical series of 1,239 cases Int J Clin Exp Med 2014;7(12):5696-5700 www.ijcem.com /ISSN:1940-5901/IJCEM0002668 Original Article The potential risk factors for atypical and anaplastic meningiomas: clinical series of 1,239 cases Ruo-Fei

More information

Characterization of morphologically benign biologically aggressive meningiomas

Characterization of morphologically benign biologically aggressive meningiomas Characterization of morphologically benign biologically aggressive meningiomas Original Article Shalinee Rao, N. Sadiya, Saraswathi Doraiswami, D. Prathiba Department of Pathology, Sri Ramachandra Medical

More information

Histopathology and MIB-1 Labeling Index Predicted Recurrence of Meningiomas. A Proposal of Diagnostic Criteria for Patients with Atypical Meningioma

Histopathology and MIB-1 Labeling Index Predicted Recurrence of Meningiomas. A Proposal of Diagnostic Criteria for Patients with Atypical Meningioma 1538 Histopathology and MIB-1 Labeling Index Predicted Recurrence of Meningiomas A Proposal of Diagnostic Criteria for Patients with Atypical Meningioma Donald Ming-Tak Ho, M.D. 1,2 Chih-Yi Hsu, M.D. 1,2

More information

Atypical and anaplastic meningiomas

Atypical and anaplastic meningiomas REVIEW DIAGNOSIS AND TREATMENT OF ATYPICAL AND ANAPLASTIC MENINGIOMAS: A REVIEW Ashok Modha, M.D. Neurosurgery Service, Memorial Sloan-Kettering Cancer Center and the Department of Neurological Surgery,

More information

Factors associated with survival in patients with meningioma

Factors associated with survival in patients with meningioma Factors associated with survival in patients with meningioma Bridget J. McCarthy, Ph.D., Faith Davis, Ph.D., Sally Freels, Ph.D., Tanya S. Surawicz, M.P.H., Denise Damek, M.D., James Grutsch, Ph.D., Herman

More information

Meningiomas account for approximately 4% of all

Meningiomas account for approximately 4% of all Intraorbital Meningiomas A Pathologic Review Using Current World Health Organization Criteria Deepali Jain, MD; Katayoon B. Ebrahimi, MD; Neil R. Miller, MD; Charles G. Eberhart, MD, PhD N Context. Meningiomas

More information

WHO [2007] GRADING OF MENINGIOMA

WHO [2007] GRADING OF MENINGIOMA SAS Journal of Surgery ISSN 2454-5104 SAS J. Surg., Volume-3; Issue-1 (Jan, 2017); p-25-29 Available online at http://sassociety.com/sasjs/ Original Research Article Histopathological analysis of meningiomas-

More information

Postoperative LINAC-Based Stereotactic Radiotherapy for Grade I Intracranial Meningioma in Subtype Classification

Postoperative LINAC-Based Stereotactic Radiotherapy for Grade I Intracranial Meningioma in Subtype Classification Postoperative LINAC-Based Stereotactic Radiotherapy for Grade I Intracranial Meningioma in Subtype Classification Peerapong Lueangapapong MD*, Mantana Dhanachai MD**, Ake Hansasuta MD* * Division of Neurosurgery,

More information

HISTOPATHOLOGICAL STUDY OF MENINGIOMA IN CIVIL

HISTOPATHOLOGICAL STUDY OF MENINGIOMA IN CIVIL IJCRR Vol 05 issue 03 Section: Healthcare Category: Research Received on: 23/12/12 Revised on: 14/01/13 Accepted on: 03/02/13 HISTOPATHOLOGICAL STUDY OF MENINGIOMA IN CIVIL HOSPITAL, AHMEDABAD Smita Shah,

More information

Factors associated with survival in patients with meningioma

Factors associated with survival in patients with meningioma J Neurosurg 88:831 839, 1998 Factors associated with survival in patients with meningioma BRIDGET J. MCCARTHY, PH.D., FAITH G. DAVIS, PH.D., SALLY FREELS, PH.D., TANYA S. SURAWICZ, M.P.H., DENISE M. DAMEK,

More information

Anaplastic Pilocytic Astrocytoma: The fusion of good and bad

Anaplastic Pilocytic Astrocytoma: The fusion of good and bad Anaplastic Pilocytic Astrocytoma: The fusion of good and bad Alexandrina Nikova 1, Charalampos-Chrysovalantis Chytoudis-Peroudis 2, Penelope Korkolopoulou 3 and Dimitrios Kanakis 4 Abstract 5 Pilocytic

More information

Prognostic factors in atypical meningioma

Prognostic factors in atypical meningioma Romanian Neurosurgery Volume XXXI Number 2 2017 April-June Article Prognostic factors in atypical meningioma A.I. Cucu, Claudia Florida Costea, I. Poeată, Dana Mihaela Turliuc ROMANIA DOI: 10.1515/romneu-2017-0025

More information

MENINGIOMA: A CLINICOPATHOLOGICAL EVALUATION. Nasrin Samadi & Seyed Ali Ahmadi

MENINGIOMA: A CLINICOPATHOLOGICAL EVALUATION. Nasrin Samadi & Seyed Ali Ahmadi Malaysian Journal of Medical Sciences, Vol. 14, No. 1, January 2007 (46-52) ORIGINAL ARTICLE MENINGIOMA: A CLINICOPATHOLOGICAL EVALUATION Nasrin Samadi & Seyed Ali Ahmadi Department of Pathology, Sina

More information

Predictive value of brain edema in preoperative computerized tomography scanning on the recurrence of meningioma

Predictive value of brain edema in preoperative computerized tomography scanning on the recurrence of meningioma Alexandria Journal of Medicine (2012) 48, 373 379 Alexandria University Faculty of Medicine Alexandria Journal of Medicine www.sciencedirect.com ORIGINAL ARTICLE Predictive value of brain edema in preoperative

More information

Peritoneal Involvement in Stage II Colon Cancer

Peritoneal Involvement in Stage II Colon Cancer Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.

More information

Rhabdoid Meningioma In A Background Of Atypical Meningioma With Lipomatous Metaplasia: Case Report And Review Of Literature

Rhabdoid Meningioma In A Background Of Atypical Meningioma With Lipomatous Metaplasia: Case Report And Review Of Literature ISPUB.COM The Internet Journal of Neurosurgery Volume 5 Number 1 Rhabdoid Meningioma In A Background Of Atypical Meningioma With Lipomatous Metaplasia: Case Report And Review Of Literature S Shuja, T Lucey,

More information

CNS TUMORS. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)

CNS TUMORS. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) CNS TUMORS D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) CNS TUMORS The annual incidence of intracranial tumors of the CNS ISmore than intraspinal tumors May be Primary or Secondary

More information

MENINGIOMA: A CLINICOPATHOLOGICAL EVALUATION. Nasrin Samadi & Seyed Ali Ahmadi

MENINGIOMA: A CLINICOPATHOLOGICAL EVALUATION. Nasrin Samadi & Seyed Ali Ahmadi Malaysian Journal of Medical Sciences, Vol. 4, No., January 7 (46-5) ORIGINAL ARTICLE Department of Pathology, Sina Hospital, Hassan Abad Square, Tehran 64, Iran As yet no unifying grading system for meningiomas

More information

Supratentorial multiple little meningiomas with transitory stroke symptoms like. MRI case presentation

Supratentorial multiple little meningiomas with transitory stroke symptoms like. MRI case presentation 114 Romanian Neurosurgery (2010) XVII 1: 114-121 Supratentorial multiple little meningiomas with transitory stroke symptoms like. MRI case presentation E. Moldovanu 1,2, Adriana Moldovanu 1,2, Carmen Gherman

More information

Clinical and radiological features related to the growth potential of meningioma

Clinical and radiological features related to the growth potential of meningioma Neurosurg Rev (2006) 29:293 297 DOI 10.1007/s10143-006-0039-3 ORIGINAL ARTICLE Clinical and radiological features related to the growth potential of meningioma Hidetoshi Kasuya & Osami Kubo & Masahiko

More information

Intracranial Meningioma Surgery Outcome the Impact of Preoperative Neuroimaging

Intracranial Meningioma Surgery Outcome the Impact of Preoperative Neuroimaging Prague Medical Report / Vol. 107 (2006) No. 3, p. 327 334 327) Intracranial Meningioma Surgery Outcome the Impact of Preoperative Neuroimaging Kozler P. 1, Beneš V. 1, Netuka D. 1, Kramář F. 1, Charvát

More information

A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas

A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas Ferraro et al. Radiation Oncology 2014, 9:38 RESEARCH Open Access A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas Daniel J Ferraro

More information

Neuroendocrine Lung Tumors Myers

Neuroendocrine Lung Tumors Myers Diagnosis and Classification of Neuroendocrine Lung Tumors Jeffrey L. Myers, M.D. A. James French Professor Director, Anatomic Pathology & MLabs University of Michigan, Ann Arbor, MI myerjeff@umich.edu

More information

International Society of Gynecological Pathologists Symposium 2007

International Society of Gynecological Pathologists Symposium 2007 International Society of Gynecological Pathologists Symposium 2007 Anais Malpica, M.D. Department of Pathology The University of Texas M.D. Anderson Cancer Center Grading of Ovarian Cancer Histologic grade

More information

The Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC)

The Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC) The Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC) Disclosure None Background Torino, Italy LCNC Rare tumor (2% to 3% all resected primary lung cancers) Preoperative

More information

Giant wing sphenoid meningioma with principal manifestation depression

Giant wing sphenoid meningioma with principal manifestation depression Romanian Journal of Morphology and Embryology 2009, 50(4):713 717 CASE REPORT Giant wing sphenoid meningioma with principal manifestation depression ADELA MAGDALENA CIOBANU 1), M. GH. LISIEVICI 2), TEODORA

More information

Pleomorphic carcinoma of the lung: which CT findings predict poor prognosis?

Pleomorphic carcinoma of the lung: which CT findings predict poor prognosis? Pleomorphic carcinoma of the lung: which CT findings predict poor prognosis? Poster No.: C-1887 Congress: ECR 2015 Type: Scientific Exhibit Authors: A. Fujisaki, T. Aoki, S. Kinoshita, Y. Hayashida, Y.

More information

Case year old female presented with asymmetric enlargement of the left lobe of the thyroid

Case year old female presented with asymmetric enlargement of the left lobe of the thyroid Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.

More information

Case 4 Diagnosis 2/21/2011 TGB

Case 4 Diagnosis 2/21/2011 TGB Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.

More information

Anaplastic Meningioma Presenting as a Left Parietal Mass: A Case Report

Anaplastic Meningioma Presenting as a Left Parietal Mass: A Case Report ISSN 1941-5923 DOI: 10.12659/AJCR.905067 Received: 2017.04.27 Accepted: 2017.07.24 Published: 2017.11.04 Anaplastic Meningioma Presenting as a Left Parietal Mass: A Case Report Authors Contribution: Study

More information

11/27/2017. Modern Treatment of Meningiomas. Disclosures. Modern is Better? No disclosures relevant to this presentation

11/27/2017. Modern Treatment of Meningiomas. Disclosures. Modern is Better? No disclosures relevant to this presentation Modern Treatment of Meningiomas Michael A. Vogelbaum MD, PhD Professor of Neurosurgery Cleveland Clinic Disclosures No disclosures relevant to this presentation IP and royalties related to drug and device

More information

We have previously reported good clinical results

We have previously reported good clinical results J Neurosurg 113:48 52, 2010 Gamma Knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional

More information

Histomorphological Spectrum of Meningioma with Variants and Grading

Histomorphological Spectrum of Meningioma with Variants and Grading Available online at www.jsciachv.com JOURNAL OF SCIENTIFIC ACHIEVEMENTS VOLUME 2, ISSUE 5, MAY 2017, PAGE: 18 22 RESEARCH ARTICLE Histomorphological Spectrum of Meningioma with Variants and Grading Abu

More information

Astroblastoma: Radiologic-Pathologic Correlation and Distinction from Ependymoma

Astroblastoma: Radiologic-Pathologic Correlation and Distinction from Ependymoma AJNR Am J Neuroradiol 23:243 247, February 2002 Case Report Astroblastoma: Radiologic-Pathologic Correlation and Distinction from Ependymoma John D. Port, Daniel J. Brat, Peter C. Burger, and Martin G.

More information

G3.02 The malignant potential of the neoplasm should be recorded. CG3.02a

G3.02 The malignant potential of the neoplasm should be recorded. CG3.02a G3.02 The malignant potential of the neoplasm should be recorded. CG3.02a Conventional adrenocortical neoplasm. Each of the below parameters is scored 0 when absent and 1 when present. 3 or more of these

More information

Prognostic significance of stroma tumorinfiltrating lymphocytes according to molecular subtypes of breast cancer

Prognostic significance of stroma tumorinfiltrating lymphocytes according to molecular subtypes of breast cancer Prognostic significance of stroma tumorinfiltrating lymphocytes according to molecular subtypes of breast cancer Hee Jung Kwon, Nuri Jang, Min Hui Park, Young Kyung Bae Department of Pathology, Yeungnam

More information

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 19/May 12, 2014 Page 5307

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 19/May 12, 2014 Page 5307 PROGNOSTIC SIGNIFICANCE OF PROLIFERATIVE ACTIVITY (KI67 EXPRESSION) IN OSTEOSARCOMA IN CHILDREN Moumita Paul 1, Arnab Karmakar 2, Uttara Chatterjee 3, Uttam Kumar Saha 4, Koushik Saha 5, Nanda Dulal Chatterjee

More information

PROCARBAZINE, lomustine, and vincristine (PCV) is

PROCARBAZINE, lomustine, and vincristine (PCV) is RAPID PUBLICATION Procarbazine, Lomustine, and Vincristine () Chemotherapy for Anaplastic Astrocytoma: A Retrospective Review of Radiation Therapy Oncology Group Protocols Comparing Survival With Carmustine

More information

Disclosure of Relevant Financial Relationships

Disclosure of Relevant Financial Relationships Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS

More information

Prognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk

Prognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk 843 Prognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk Tadashi Hasegawa, M.D. 1 Seiichiro Yamamoto, Ph.D. 2

More information

3/27/2017. Disclosure of Relevant Financial Relationships

3/27/2017. Disclosure of Relevant Financial Relationships Ophthalmic Pathology Evening Specialty Conference USCAP 2017 5 th March, 2017 Mukul K. Divatia, MD Assistant Professor Department of Pathology & Genomic Medicine Weill Cornell Medical College Houston Methodist

More information

Slide seminar. Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana

Slide seminar. Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana Slide seminar Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana Case 5 A 57-year-old man with a dermal/subcutaneous lesion on the scalp, which was interpreted

More information

IAP XXVI International Congress Slide Seminar 07 (SS07)

IAP XXVI International Congress Slide Seminar 07 (SS07) IAP XXVI International Congress Slide Seminar 07 (SS07) Pitfalls in Surgical Neuropathology Case 6 Richard A. Prayson, M.D. Cleveland Clinic Foundation Clinical History 64M S/P resection of pituitary adenoma

More information

MANAGEMENT N OF PRIMARY BRAIN TUMOURS IN THE ELDERLY

MANAGEMENT N OF PRIMARY BRAIN TUMOURS IN THE ELDERLY MANAGEMENT N OF PRIMARY BRAIN TUMOURS IN THE ELDERLY Meningioma, Glioma, Lymphoma Cornu Ph, Keime-Guibert F, Hoang-Xuan K, Pierga JY, Delattre JY Neuro-oncology Group of Pitie-Salpetriere hospital-paris-france

More information

Prognostic value of the 8 th tumor-node-metastasis classification for follicular carcinoma and poorly differentiated carcinoma of the thyroid in Japan

Prognostic value of the 8 th tumor-node-metastasis classification for follicular carcinoma and poorly differentiated carcinoma of the thyroid in Japan 2018, 65 (6), 621-627 ORIGINAL Prognostic value of the 8 th tumor-node-metastasis classification for follicular carcinoma and poorly differentiated carcinoma of the thyroid in Japan Yasuhiro Ito 1), Akira

More information

ORIGINAL ARTICLE. Clinical Node-Negative Thick Melanoma

ORIGINAL ARTICLE. Clinical Node-Negative Thick Melanoma ORIGINAL ARTICLE Clinical Node-Negative Thick Melanoma George I. Salti, MD; Ashwin Kansagra, MD; Michael A. Warso, MD; Salve G. Ronan, MD ; Tapas K. Das Gupta, MD, PhD, DSc Background: Patients with T4

More information

Clinical analysis of 29 cases of nasal mucosal malignant melanoma

Clinical analysis of 29 cases of nasal mucosal malignant melanoma 1166 Clinical analysis of 29 cases of nasal mucosal malignant melanoma HUANXIN YU and GANG LIU Department of Otorhinolaryngology Head and Neck Surgery, Tianjin Huanhu Hospital, Tianjin 300060, P.R. China

More information

Case Report Xanthomatous meningioma: a case report with review of the literature

Case Report Xanthomatous meningioma: a case report with review of the literature Int J Clin Exp Pathol 2013;6(10):2242-2246 www.ijcep.com /ISSN:1936-2625/IJCEP1308033 Case Report Xanthomatous meningioma: a case report with review of the literature Mitsuaki Ishida 1, Tadateru Fukami

More information

Immunohistochemical Staining for Claudin-1 Can Help Distinguish Meningiomas From Histologic Mimics

Immunohistochemical Staining for Claudin-1 Can Help Distinguish Meningiomas From Histologic Mimics Anatomic Pathology / CLAUDIN-1 IN MENINGIOMAS Immunohistochemical Staining for Claudin-1 Can Help Distinguish Meningiomas From Histologic Mimics Hejin P. Hahn, MD, PhD, Elizabeth A. Bundock, MD, PhD, and

More information

Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer

Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors

More information

Mitosin and phh3 predict poorer survival in astrocytomas WHO grades II and III

Mitosin and phh3 predict poorer survival in astrocytomas WHO grades II and III JCP Online First, published on July 17, 2015 as 10.1136/jclinpath-2015-202983 Original article Mitosin and phh3 predict poorer survival in astrocytomas WHO grades II and III R K Varughese, 1 T Lind-Landström,

More information

Xiang Hu*, Liang Cao*, Yi Yu. Introduction

Xiang Hu*, Liang Cao*, Yi Yu. Introduction Original Article Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7 th edition and JCGS 13 th edition N-classification systems Xiang Hu*, Liang

More information

Large Colorectal Adenomas An Approach to Pathologic Evaluation

Large Colorectal Adenomas An Approach to Pathologic Evaluation Anatomic Pathology / LARGE COLORECTAL ADENOMAS AND PATHOLOGIC EVALUATION Large Colorectal Adenomas An Approach to Pathologic Evaluation Elizabeth D. Euscher, MD, 1 Theodore H. Niemann, MD, 1 Joel G. Lucas,

More information

A Study of Meningiomas in Tertiary Care Center in South India.

A Study of Meningiomas in Tertiary Care Center in South India. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 10 Ver. XII (October. 2016), PP 07-12 www.iosrjournals.org A Study of Meningiomas in Tertiary

More information

Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival

Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival MOLECULAR AND CLINICAL ONCOLOGY 7: 1083-1088, 2017 Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival FARUK TAS

More information

Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy

Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy Korean J Hepatobiliary Pancreat Surg 2011;15:152-156 Original Article Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy Suzy Kim 1,#, Kyubo

More information

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy. 30 th Congress of the European Society of Pathology Tuesday, September 11, 2018 The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

More information

Solitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation

Solitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation 246) Prague Medical Report / Vol. 113 (2012) No. 3, p. 246 250 Solitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation Sfoungaristos S., Papatheodorou M., Kavouras

More information

Collection of Recorded Radiotherapy Seminars

Collection of Recorded Radiotherapy Seminars IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org The Role of Radiosurgery in the Treatment of Gliomas Luis Souhami, MD Professor Department of Radiation

More information

Treatment Strategy of Intracranial Hemangiopericytoma

Treatment Strategy of Intracranial Hemangiopericytoma ORIGINAL ARTICLE Brain Tumor Res Treat 2015;3(2):68-74 / pissn 2288-2405 / eissn 2288-2413 http://dx.doi.org/10.14791/btrt.2015.3.2.68 Treatment Strategy of Intracranial Hemangiopericytoma Young-Joo Kim

More information

ORIGINAL ARTICLE. Predicting the Prognosis of Oral Squamous Cell Carcinoma After First Recurrence

ORIGINAL ARTICLE. Predicting the Prognosis of Oral Squamous Cell Carcinoma After First Recurrence ORIGINAL ARTICLE Predicting the Prognosis of Oral Squamous Cell Carcinoma After First Recurrence Michael D. Kernohan, FDSRCS, FRCS, MSc; Jonathan R. Clark, FRACS; Kan Gao, BEng; Ardalan Ebrahimi, FRACS;

More information

The effect of delayed adjuvant chemotherapy on relapse of triplenegative

The effect of delayed adjuvant chemotherapy on relapse of triplenegative Original Article The effect of delayed adjuvant chemotherapy on relapse of triplenegative breast cancer Shuang Li 1#, Ding Ma 2#, Hao-Hong Shi 3#, Ke-Da Yu 2, Qiang Zhang 1 1 Department of Breast Surgery,

More information

Anna Maria Buccoliero Department of Biomedicine, Careggi Hospital Florence

Anna Maria Buccoliero Department of Biomedicine, Careggi Hospital Florence PEDIATRIC RHABDOID MENINGIOMA Anna Maria Buccoliero Department of Biomedicine, Careggi Hospital Florence CLINICAL HISTORY A 3-year-old boy, with a recent history of seizures, was admitted to the Neurosurgery

More information

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14 Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14 Contents 14. Neuroendocrine Tumours 161 14.1. Diagnostic algorithm

More information

Chibueze Onyemkpa 1, Alan Davis 1, Michael McLeod 1, Tolutope Oyasiji 1,2. Original Article

Chibueze Onyemkpa 1, Alan Davis 1, Michael McLeod 1, Tolutope Oyasiji 1,2. Original Article Original Article Typical carcinoids, goblet cell carcinoids, mixed adenoneuroendocrine carcinomas, neuroendocrine carcinomas and adenocarcinomas of the appendix: a comparative analysis of survival profile

More information

Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis

Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis https://doi.org/10.1186/s13104-018-3319-4 BMC Research Notes RESEARCH NOTE Open Access Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis Atif Ali

More information

ACCME/Disclosures. Cribriform Lesions of the Prostate. Case

ACCME/Disclosures. Cribriform Lesions of the Prostate. Case Cribriform Lesions of the Prostate Ming Zhou, MD, PhD Departments of Pathology and Urology New York University Langone Medical Center New York, NY Ming.Zhou@NYUMC.ORG ACCME/Disclosures The USCAP requires

More information

Leiomyosarcoma of the inferior vena cava: 1 case. B. Bancel, A. Rode, C. Ducerf. Hôpital CROIX ROUSSE LYON. Case report

Leiomyosarcoma of the inferior vena cava: 1 case. B. Bancel, A. Rode, C. Ducerf. Hôpital CROIX ROUSSE LYON. Case report Leiomyosarcoma of the inferior vena cava: 1 case B. Bancel, A. Rode, C. Ducerf Hôpital CROIX ROUSSE LYON Bucharest Nov 2011 Case report 34 yr-old woman, no antecedent Sept 2004: Abdominal upper right quadrant

More information

Current Concept in Ovarian Carcinoma: Pathology Perspectives

Current Concept in Ovarian Carcinoma: Pathology Perspectives Current Concept in Ovarian Carcinoma: Pathology Perspectives Rouba Ali-Fehmi, MD Professor of Pathology The Karmanos Cancer Institute, Wayne State University School of Medicine Current Concept in Ovarian

More information

Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05

Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05 Abstract No.: ABS-0075 Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer 2018/04/05 Cheol Min Kang Department of surgery, University of Ulsan

More information

Introduction ORIGINAL RESEARCH

Introduction ORIGINAL RESEARCH Cancer Medicine ORIGINAL RESEARCH Open Access The effect of radiation therapy in the treatment of adult soft tissue sarcomas of the extremities: a long- term community- based cancer center experience Jeffrey

More information

Malignant Transformation of Craniopharyngioma without Radiation Therapy: Case Report and Review of the Literature

Malignant Transformation of Craniopharyngioma without Radiation Therapy: Case Report and Review of the Literature Case Report J Korean Neurosurg Soc 60 (1) : 108-113, 2017 https://doi.org/10.3340/jkns.2015.0707.022 pissn 2005-3711 eissn 1598-7876 Malignant Transformation of Craniopharyngioma without Radiation Therapy:

More information

Division of Pathology

Division of Pathology Case 38 Adult woman with a 35mm right breast lump at the 10 o clock position. Excision performed. (Case contributed by Dr Mihir Gudi, KKH) Division of Pathology Merlion, One Fullerton Singapore Diagnosis

More information

Utility of 18 F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer

Utility of 18 F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer Utility of F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer Ngoc Ha Le 1*, Hong Son Mai 1, Van Nguyen Le 2, Quang Bieu Bui 2 1 Department

More information

Upper urinary tract urothelial carcinomas (UTUC)

Upper urinary tract urothelial carcinomas (UTUC) Prognostic Role of Lymphovascular Invasion in Patients with Urothelial Carcinoma of the Upper Urinary Tract Manel Mellouli 1 *, Slim Charfi 1, Walid Smaoui 2, Rim Kallel 1, Abdelmajid Khabir 1, Mehdi Bouacida

More information

USCAP 2012: Companion Meeting of the AAOOP. Update on lacrimal gland neoplasms: Molecular pathology of interest

USCAP 2012: Companion Meeting of the AAOOP. Update on lacrimal gland neoplasms: Molecular pathology of interest USCAP 2012: Companion Meeting of the AAOOP Vancouver BC, Canada, March 17, 2012 Update on lacrimal gland neoplasms: Molecular pathology of interest Valerie A. White MD, MHSc, FRCPC Department of Pathology

More information

Survival of High Grade Glioma Patients Treated by Three Radiation Schedules with Chemotherapy: A Retrospective Comparative Study

Survival of High Grade Glioma Patients Treated by Three Radiation Schedules with Chemotherapy: A Retrospective Comparative Study Original Article Research in Oncology June 2017; Vol. 13, No. 1: 18-22. DOI: 10.21608/resoncol.2017.552.1022 Survival of High Grade Glioma Patients Treated by Three Radiation Schedules with Chemotherapy:

More information

After primary tumor treatment, 30% of patients with malignant

After primary tumor treatment, 30% of patients with malignant ESTS METASTASECTOMY SUPPLEMENT Alberto Oliaro, MD, Pier L. Filosso, MD, Maria C. Bruna, MD, Claudio Mossetti, MD, and Enrico Ruffini, MD Abstract: After primary tumor treatment, 30% of patients with malignant

More information

Dynamic Contrast-Enhanced Perfusion MR Imaging Measurements of Endothelial Permeability: Differentiation between Atypical and Typical Meningiomas

Dynamic Contrast-Enhanced Perfusion MR Imaging Measurements of Endothelial Permeability: Differentiation between Atypical and Typical Meningiomas AJNR Am J Neuroradiol 24:1554 1559, September 2003 Dynamic Contrast-Enhanced Perfusion MR Imaging Measurements of Endothelial Permeability: Differentiation between Atypical and Typical Meningiomas Stanley

More information

Survival and Intracranial Control of Patients With 5 or More Brain Metastases Treated With Gamma Knife Stereotactic Radiosurgery

Survival and Intracranial Control of Patients With 5 or More Brain Metastases Treated With Gamma Knife Stereotactic Radiosurgery ORIGINAL ARTICLE Survival and Intracranial Control of Patients With 5 or More Brain Metastases Treated With Gamma Knife Stereotactic Radiosurgery Ann C. Raldow, BS,* Veronica L. Chiang, MD,w Jonathan P.

More information

Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers

Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers 日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu

More information

Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience

Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience Curzon M, Curzon C, Heidel RE, Desai P, McLoughlin J, Panella T, Bell

More information

Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD

Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD ASSOCIATE PROFESSOR OF MEDICINE UNIVERSITY OF MICHIGAN MICHIGAN AACE 2018 ANNUAL MEETING Thyroid Cancer: When Not to Treat? FOCUS WILL BE ON LOW-RISK

More information

Surgical treatment of thymoma: an 11-year experience with 761 patients

Surgical treatment of thymoma: an 11-year experience with 761 patients European Journal of Cardio-Thoracic Surgery 49 (2016) 1144 1149 doi:10.1093/ejcts/ezv288 Advance Access publication 30 August 2015 ORIGINAL ARTICLE Cite this article as: Zhao Y, Shi J, Fan L, Hu D, Yang

More information

Salvage prostatectomy for post-radiation adenocarcinoma with treatment effect: Pathological and oncological outcomes

Salvage prostatectomy for post-radiation adenocarcinoma with treatment effect: Pathological and oncological outcomes ORIGINAL RESEARCH Salvage prostatectomy for post-radiation adenocarcinoma with treatment effect: Pathological and oncological outcomes Michael J. Metcalfe, MD ; Patricia Troncoso, MD 2 ; Charles C. Guo,

More information

Perry A et al., Cancer 92:701, 2001

Perry A et al., Cancer 92:701, 2001 EMBOLIZED MENINGIOMAS Perry A et al., Cancer 92:71, 21 MENINGIOMA PREDISPOSITION Neurofibromatosis 2 () Prior Irradiation Trauma? Cowden s syndrome? Gorlin s nevoid basal cell syndrome? Li Fraumeni syndrome?

More information

ELIZABETH CEDARS DR. KOREY HOOD Available September 29

ELIZABETH CEDARS DR. KOREY HOOD Available September 29 ELIZABETH CEDARS DR. KOREY HOOD Available September 29 Title and Investigators Optimizing Surgical Management of Thyroid Cancer: Using Surgeon-performed Ultrasound to Predict Extrathyroidal Extension of

More information

Lymph node ratio as a prognostic factor in stage III colon cancer

Lymph node ratio as a prognostic factor in stage III colon cancer Lymph node ratio as a prognostic factor in stage III colon cancer Emad Sadaka, Alaa Maria and Mohamed El-Shebiney. Clinical Oncology department, Faculty of Medicine, Tanta University, Egypt alaamaria1@hotmail.com

More information

Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance

Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance & 2006 USCAP, Inc All rights reserved 0893-3952/06 $30.00 www.modernpathology.org Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance Charles C Guo 1 and

More information

Although the international TNM classification system

Although the international TNM classification system Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru

More information

As with other brain tumors, patients with meningiomas

As with other brain tumors, patients with meningiomas 124 It s Not Your Run of the Mill Meningioma: Characteristics Differentiating Low-Grade From High-Grade Meningeal Tumors Eileen Bohan, Deanna Glass-Macenka ABSTRACT Approximately 30% of primary brain tumors

More information

Ultrasound-Guided Fine-Needle Aspiration of Thyroid Nodules: New events

Ultrasound-Guided Fine-Needle Aspiration of Thyroid Nodules: New events Ultrasound-Guided Fine-Needle Aspiration of Thyroid Nodules: New events Sandrine Rorive, M.D., PhD. Erasme Hospital - Université Libre de Bruxelles (ULB) INTRODUCTION The assessment of thyroid nodules

More information

Prostate Immunohistochemistry. Literature Interpretation: Caveats. Must be aware of staining pattern of antibody in the relevant tissue

Prostate Immunohistochemistry. Literature Interpretation: Caveats. Must be aware of staining pattern of antibody in the relevant tissue IHC Interpretation: General Principles (1) Prostate Immunohistochemistry Murali Varma Cardiff, UK wptmv@cf.ac.uk Sarajevo Nov 2013 Must be aware of staining pattern of antibody in the relevant tissue Nuclear/cytoplasmic/membranous

More information